Study of Rare Tumors in the Thoraco-Abdominal Area
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
Recruiting
Observational Study
Rare Malignant Neoplasm
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,100 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Who this trial is looking for
This trial is looking for patients with rare and complex tumors. Participants will share their diagnosis and treatment details from the past and ongoing treatments until the end of 2025.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a diagnosis of a rare or complex malignant tumor.
- I have given my informed consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms.
The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with histologic diagnosis of rare or highly complex malignant neoplasm
* informed consent
Exclusion Criteria:
* none
Contacts